ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleisch, M.
Right arrow Articles by Scherer, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleisch, M.
Right arrow Articles by Scherer, T.
Eur Respir J 2000; 15: 205-208
Copyright © ERS Journals Ltd 2000

Case Studies

Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment

MC Fleisch, F Blauer, JG Gubler, M Kuhn, and TA Scherer

Drugs are well known causes of eosinophilic lung disease. In many patients, symptoms increase slowly, pulmonary infiltrates and eosinophilia progress over weeks, and resolve upon withdrawal of the offending agent. Rarely, the disease presents like acute eosinophilic pneumonia with acute onset of symptoms and rapidly progressing infiltrates which may be associated with respiratory failure. This report describe a case of venlafaxine-induced acute eosinophilic pneumonia causing respiratory insufficiency that rapidly resolved upon institution of corticosteroid treatment. This 5-hydroxytryptamine and noradrenaline reuptake inhibitor was previously not known to cause lung or peripheral blood eosinophilia. Considering the increasing use of this class of medication physicians have to be aware of this life-threatening and fully reversible complication.


This article has been cited by other articles:


Home page
 PsychosomaticsHome page
M. J. M. Vazquez and B. Carretero Quevedo
Pneumonitis Related to Venlafaxine
Psychosomatics, February 1, 2008; 49(1): 84 - 85.
[Full Text] [PDF]

Home page
 ChestHome page
V. J. Espeleta, W. H. Moore, P. B. Kane, and D. Baram
Eosinophilic Pneumonia Due to Duloxetine
Chest, March 1, 2007; 131(3): 901 - 903.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. V. Salud II and N. Dean
TOO MUCH OF A GOOD THING: ACUTE EOSINOPHILIC PNEUMONIA WITH A "NEW" ANTI-DEPRESSANT
Chest Meeting Abstracts, October 1, 2005; 128(4): 427S - 427S.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
A. Karakatsani, A. Chroneou, N. G. Koulouris, D. Orphanidou, and J. Jordanoglou
Meloxicam-induced pulmonary infiltrates with eosinophilia: a case report
Rheumatology, September 1, 2003; 42(9): 1112 - 1113.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Drent, S. Singh, A. P. M. Gorgels, D. M. Hansell, O. Bekers, A. G. Nicholson, R. J. van Suylen, and R. M. du Bois
Drug-induced Pneumonitis and Heart Failure Simultaneously Associated with Venlafaxine
Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 958 - 961.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the European Respiratory Society.